Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114725) titled 'Clinical trial on the effectiveness of intravesical hematoporphyrin infusion photodynamic therapy combined with intravesical mitomycin in the treatment of high-risk nonmuscular invasive bladder cancer' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai General Hospital
Condition:
Bladder Cancer
Intervention:
PDT+Mitomycin(RCT):PDT+Mitomycin
PDT(RCT):PDT
Mitomycin(RCT):Mitomycin
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: PDT+Mitomycin(RCT):40;PDT(RCT):40;Mitomycin(RCT):40;PDT+Mitomycin(single-ar...